Evaluation of efficacy and safety of femtosecond laser-assisted cataract surgery in patients with Fuchs' endothelial corneal dystrophy

Session Details

Session Title: Femtolaser-Assisted Cataract Surgery (FLACS) II

Session Date/Time: Monday 09/10/2017 | 08:30-10:30

Paper Time: 08:48

Venue: Room 4.4

First Author: : J.Szaflik POLAND

Co Author(s): :    T. Galecki   M. Lazicka-Galecka   J. Szaflik              

Abstract Details

Purpose:

Evaluation of efficacy and safety of Femtosecond laser-assisted cataract surgery in patients with Fuchs’ endothelial corneal dystrophy

Setting:

Department of Ophthalmology, Medical University of Warsaw, Poland

Methods:

156 patients with cataract and FECD were enrolled. All the subjects had clinically transparent corneas, although some presented subclinical stromal edema detectable by means of confocal microscopy. None of the patients had clinically significant corneal edema. Cataract nuclei hardness were N2 to N5 according to LOCS III grading. The patients were followed up for minimum of 6 months. Pre- and post op pachymetry, endothelial cell density, BCVA and complicationc were evaluated.

Results:

Pre-operative mean minimal pachymetry (assesed by AS-OCT) was 554.37 µm (479-639), mean central or paracentral endothelial density (assesed by ConfoScan) 963 cells/mm² (410-1732), BCVA 0.36 (0.05-0.8). All the surgeries were uneventful. Most of the patients did not develope clinically significant corneal edema after the surgery. In 23 cases minor or moderate edema or corneal folds were observed and retreated in few days after the surgery. In two cases, because of corneal decompensation, endothelial keratoplasty were performed. BCVA improved to mean 0.78 (0.4-1.0), mean minimal pachymetry was 562.7 µm, (485-628), mean endothelial density 955 cells/mm² (405-1692).

Conclusions:

Femtosecond-laser assisted cataract surgery was safe and effective procedure, reducing intraoperative trauma in patients with FECD. Proper preoperative assessment and appropriate technique of the manual part remain important for optimal outcomes.

Financial Disclosure:

NONE